This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
GE HealthCare Stock Before Q4 Earnings: To Buy or Not to Buy?
by Zacks Equity Research
GEHC heads into fourth-quarter earnings with steady demand and strong product momentum, though tariffs and investments may keep margins in focus.
CAHPositive Net Change MASINegative Net Change DXCMPositive Net Change GEHCPositive Net Change
medical medical-devices
Silver Economy Boom: Investing in Healthcare's Aging Tailwinds
by Urmimala Biswas
An aging population is reshaping healthcare, with BSX, RMD, ABBV and AMGN positioned to benefit from rising senior care demand.
ABTPositive Net Change BSXNegative Net Change AMGNNegative Net Change MDTNegative Net Change RMDPositive Net Change ABBVPositive Net Change
biotechs cancer healthcare hospitals medical medical-devices pharmaceuticals
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test
by Zacks Equity Research
NTRA submits FDA PMA for Signatera CDx, aiming to guide bladder cancer treatment with MRD testing after positive phase 3 trial results.
BSXNegative Net Change IDXXPositive Net Change STENegative Net Change NTRANegative Net Change
medical medical-devices
DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand
by Zacks Equity Research
DVA reports a fourth-quarter 2025 earnings and revenue beat as margins expanded and full-year adjusted EPS rose by double digits.
BSXNegative Net Change DGXNegative Net Change DVAPositive Net Change GMEDNegative Net Change
earnings medical medical-devices
Graco Inc. (GGG)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
GGGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy, Sell, or Hold McKesson Before Q3 Earnings?
by Zacks Equity Research
MCK approaches third-quarter earnings with strong growth expectations, but limited visibility on margins and investments keeps the outlook cautious.
CAHPositive Net Change MCKPositive Net Change MASINegative Net Change DXCMPositive Net Change
medical medical-devices
MedTech Stocks to Watch for Earnings on Feb. 4: BSX, ALGN & More
by Moumi Mondal
Q4 earnings season is here, and BSX, ALGN, STE and TECH are set to report amid slowing sector profits but steady revenue growth.
BSXNegative Net Change ALGNPositive Net Change STENegative Net Change TECHNegative Net Change
earnings medical medical-devices
4 Medical Product Stocks to Watch From a Challenging Industry (Revised)
by Indrajit Bandyopadhyay
The Zacks Medical Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.
BSXNegative Net Change RMDPositive Net Change BLFSNegative Net Change PAHCPositive Net Change
medical medical-devices
BD & Envetec Showcase Closed-Loop Recycling Solution for Lab Plastics
by Zacks Equity Research
BDX completes a pilot with Envetec showing polystyrene Petri dishes can be safely recycled into new medical-grade feedstock.
BDXPositive Net Change CAHPositive Net Change COOPositive Net Change VCYTNegative Net Change
medical medical-devices
Do Options Traders Know Something About Revvity Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to RVTY stock based on the movements in the options market lately.
RVTYPositive Net Change
medical medical-devices